This topic contains a solution. Click here to go to the answer

Author Question: Firms in an oligopoly market tend to be ____ and have ____ barriers to entry. a. large (relative to ... (Read 49 times)

pragya sharda

  • Hero Member
  • *****
  • Posts: 566
Firms in an oligopoly market tend to be ____ and have ____ barriers to entry.
 a. large (relative to the total market); high.
  b. large (relative to the total market); low.
  c. small (relative to the total market); high.
  d. small (relative to the total market); low.

Question 2

Fixing a payment schedule in an agreement:
 a. allows the seller to easily access loanable funds.
  b. increases the uncertainty associated with the cost of production.
  c. allows the seller to charge a high price for his product.
  d. ensures the delivery of goods at a high price.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

reelove4eva

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

a

Answer to Question 2

A




pragya sharda

  • Member
  • Posts: 566
Reply 2 on: Jun 30, 2018
Excellent


brbarasa

  • Member
  • Posts: 308
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

There are approximately 3 million unintended pregnancies in the United States each year.

Did you know?

Giardia is one of the most common intestinal parasites worldwide, and infects up to 20% of the world population, mostly in poorer countries with inadequate sanitation. Infections are most common in children, though chronic Giardia is more common in adults.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

For a complete list of videos, visit our video library